Results 91 to 100 of about 146,743 (148)

Ferroptosis in multiple myeloma: molecular mechanisms and therapeutic opportunities. [PDF]

Front Oncol
Jiang W, Xu L, Zhu C, Bai G, Peng S, Ma N.   +5 more
europepmc   +1 more source

CAR-T therapy is the preferred option in relapsed/refractory multiple myeloma. [PDF]

Blood Adv
Banerjee R.
europepmc   +1 more source

Shikonin Promotes Apoptosis in Multiple Myeloma Cells Through the PKM2-AMPK-PGC1α Metabolic Axis. [PDF]

J Clin Lab Anal
Peng F, Gao Y, Zhang Z, Deng L, Liu H, Liang X, Liu C, Fu R.   +7 more
europepmc   +1 more source

Predictors of posttransplant measurable residual disease negativity and impact on clinical outcomes in multiple myeloma. [PDF]

Blood Adv
Bolarinwa A, Zanwar S, Abdallah N, Nagaraj M, Seth S, Buadi FK, Hayman SR, Gertz MA, Dispenzieri A, Muchtar E, Kapoor P, Gonsalves W, Kourelis T, Dingli D, Warsame R, Leung N, Cook J, Binder M, Lin Y, Hwa L, Rogers MG, Hobbs M, Fonder A, Jevremovic D, Rajkumar SV, Kumar SK.   +25 more
europepmc   +1 more source

Multiple myeloma: A tale of deregulated transcription factors. [PDF]

Hemasphere
Gómez-Echarte N, San José-Enériz E, Urizar-Compains E, Rodriguez-Otero P, Prósper F, Agirre X.   +5 more
europepmc   +1 more source

Collapsing Glomerulopathy in a Patient With Malaria and Multiple Myeloma: A Case Report. [PDF]

Case Rep Med
Harenberg M, Amann K, Zickler D.
europepmc   +1 more source